Thus, an apoB measurement includes, besides LDL, also Lp(a), IDL, VLDL and CM-remnants,46 and is recommended as (1) assessment of risk of CHD and (2) target of lipid-lowering therapy.47,48. Here, LPA is linked to coronary artery disorder.